CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 192 enrolled
Drug / intervention
ropivacaine infiltration +2 moredrug
Likely dose
intrathecal morphine 100 µgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02264821
NCT02264821Phase 3Completed

Is Continuous Wound Infusion With Ropivacaine Better Than Intrathecal Morphine for Post-caesarean Analgesia? A Prospective, Randomized, Controlled, Double Blinded Study

Dr Madeleine Wilwerth·interventional·Posted Oct 15, 2014·Updated Jun 9, 2015

In Brief

A Phase 3 clinical trial evaluating ropivacaine infiltration, intrathecal morphine, and 1 other intervention for Post Caesarean Analgesia. Completed, enrolled 192 participants across 1 site.

Detailed Summary

The aim of this study is to compare effective analgesia with continuous wound infiltration of ropivacaine through multi-holed catheter or with morphine 100 mcg added intrathecally to spinal anesthesia, after elective Caesarean delivery.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesBelgium
Collaborators--

Timeline

Phase 3CompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedOct 15, 2014
Enrollment StartFeb 1, 2012
Primary CompletionAug 1, 2014
TodayJul 2, 2026
Enrollment to primary: 2.5 yearsPosted 11.7 years ago

Interventions

ropivacaine infiltrationdrug

wound infiltration

intrathecal morphinedrug

100 µg added to the spinal anaesthesia

placebodrug

placebo in spinal anaesthesia and in wound infiltration